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ABstRAct
The aim of the study was to evaluate the antioxidant, immunomodulatory and anti-arthritic effects of turmeric 
extracts (Standard and CurQfen) on rat adjuvant arthritis. The impact of the treatment was investigated on pro- and 
antioxidant status, serum interleukins IL-17 and IL-1β, blood indices, joint swelling, and histological changes in the 
joints, liver and body weight. Both turmeric extracts improved blood indices, decreased the level of pro-inflammatory 
cytokines, and enhanced antioxidant level. Both extracts diminished swelling and normalized histological structure 
in soft periarticular tissues, synovial membrane and hyaline cartilage. No negative effect on the liver was observed. 
CurQfen was more effective than Standard extract. The strong antioxidative, anti-inflammatory and immunomodulatory 
effects of the turmeric extracts suggest their usefulness in the treatment of autoimmune arthritis as monotherapy or in 
combination with traditional anti-arthritic drugs. 
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cell infiltration and cartilage erosions. Therefore, 
AA is often used in the preclinical search for new 
anti-rheumatic drugs (ROY and GHOSH, 2013). 
Natural herbal compounds in appropriate doses 
are non-harmful and non-toxic, therefore they are 
becoming increasingly important in conventional 
Introduction
Rheumatoid arthritis (RA) is a common and 
severe autoimmune disease with no effective 
treatment so far. Rat adjuvant arthritis (AA) is 
one of the RA experimental models characterized 
by autoimmune joint damage with synovial 
hyperplasia, increased angiogenesis, inflammatory 
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medicine, including treatment of chronic diseases 
(PIROTTA, 2010). Some plants alleviate the side 
effects of traditional chemical treatment, enhance 
the beneficial effect of drugs, or prevent recurrence 
of the disease. It has been shown that the turmeric 
plant has anti-inflammatory properties and can be 
used for treatment of arthritis (TATY ANNA et al., 
2011; KERTIA et al., 2012; GUPTA et al., 2013). 
Turmeric (Curcuma longa) is rich in vitamins C, 
B1, B2, and B3, and micro and macro elements. 
It has strong antioxidant properties and eliminates 
free radicals produced by metabolic processes, 
inflammation and oxidative stress implicated in the 
pathogenesis of arthritis. Clinical and basic studies 
stress the detrimental role of reactive oxygen species 
(ROS) in chronic inflammation (FILIPPIN et al., 
2008; MIRSHAFIEY and MOHSENZADEGAN, 
2008). A pro-oxidant/antioxidant imbalance occurs 
in RA and AA due to the increase in damaging 
cellular reactions and crippled antioxidant defense 
systems (MINUZ et al., 2006). 
The impaired antioxidant system affects the 
balance of pro-inflammatory/anti-inflammatory 
cytokines, and plays an essential role in the 
pathogenesis of RA (MATEEN et al., 2016). Pro-
inflammatory cytokines, such as TNF-α and IL-1β, 
are considered to be the main pathogenic cytokines 
in RA (WAN et al., 2017; WU et al., 2018). 
They mediate the production of other cytokines, 
chemokines and degrading enzymes, reinforcing 
the progression of the disease (KAN et al., 2014; 
RAJAGOPAL et al., 2017). IL-17 is a pro-
inflammatory cytokine similar to IL-1β and TNF-α, 
and also plays an important role in the pathogenesis 
of RA (CHABAUD et al., 2000; MIOSSEC, 2003).
The aim of this study was to investigate the 
effect of two different turmeric extracts on oxidative 
stress, inflammatory and immune response in rat 
adjuvant arthritis.
Materials and methods
Materials. Freund’s Complete adjuvant (FCA) 
was purchased from Sigma Aldrich (Calbiochem, 
USA) and used to induce AA. Trichloroacetate, 
orthophosphoric, thiobarbituric, nitrogen, ascorbic 
acid, iron sulphate, ammonium molybdate, 
hydrogen peroxide, 10% neutral buffered formalin, 
hematoxylin and eosin, picrofuchsin and toluidine 
blue were obtained from Sigma-Aldrich Chemie 
and Fluka Chemie GmbH (Germany); Ketamidor 
10% from Richer Pharma AG (Wels, Austria) 
and Sedaxylan from Eurovet Animal Health B.V. 
(Netherlands); tetrachloroauric acid and tannic acid 
from Carl Roth GmbH & Co (Germany); sodium 
citrate from Penta (Czech Republic). A commercial 
ELISA Abcam® kit for IL-17 test and a Thermo 
Scientific Rat IL-1β ELISA Kit for detection of IL-
1β were used. 
Animals. Twenty-one, sexually mature, male 
Wistar rats (10 weeks of age, body weight 180-
220 g) were used for the experiment. The animals 
were housed in plastic cages and maintained 
under standard conditions, in the vivarium of 
The Department of Biomodels, State Research 
Institute Center for Innovative Medicine (Vilnius, 
Lithuania). They had free access to a standard pellet 
diet (JCS; Litagra Company Group, Lithuania) and 
drinking water. The use of animals in this study 
was in accordance with Directive 2010/63/EU of 
the European Parliament and of the Council of 22 
September 2010 on the protection of animals used 
for scientific purposes. The experiment on rats was 
performed with the prior approval of the Lithuanian 
Laboratory Animal Use Ethics Committee, under 
the State Food and Veterinary Service (No. 0177).
Adjuvant arthritis, its evaluation and treatment. 
AA was induced by injecting 0.1 mL of FCA into 
the left hind paw. The appearance of arthritis 
was evaluated clinically and histologically post-
mortem. Body weight and joint swelling changes 
were recorded 3 times a week. Two parameters were 
monitored to evaluate the pathological process in 
joints: joint swelling measured plethysmometrically 
(PVP1001; Kent Scientific Incorporation, USA) 
and the appearance of polyarthritis in other limbs 
(not injected with FCA). The effects of two dry 
turmeric extracts received from the pharmaceutical 
company Aksada: Standard (95% of curcuminoids) 
and CurQfen (Curcumin/Fenugreek Complex, 
containing 35% curcuminoids) were assessed 
continuously from the day AA was induced. 
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The rats were divided into 3 groups (7 animals 
in each): Group I was prophylactically treated 
with Standard extract (30 mg/kg), Group II - with 
CurQfen extract (30 mg/kg), and Group III was the 
control without turmeric treatment. The extracts 
were suspended in 1% starch gel and injected 
through the probe into the stomach 5 times a week 
in a volume of 1 mL. Each animal in the control AA 
group received 1 mL of starch gel as the vehicle. 
The duration of the experiment was 17 days.
 At the end of experiment the animals were 
euthanized by decapitation under ketamidor-
sedaxylan anesthesia. The overall status of the 
animals, organ weight and macroscopic changes 
were evaluated. Blood, liver and injected paws 
were collected for further investigation. Leukocyte 
count was determined using a Picoscale automatic 
blood counter (MEDICOR, Typ PS4, Hungary), 
and erythrocyte sedimentation rate (ESR) was 
estimated by the standard method. Blood samples 
were centrifuged at 800 x g for 10 min to obtain 
serum samples which were stored frozen at -20 °C 
until testing.
Pro-/antioxidant activity of blood serum. The 
concentration of malondialdehyde (MDA), catalase 
(CAT) activity and the total antioxidant activity 
(AOA) in the blood serum was investigated by the 
methods of GAVRILOV et al. (1987), KOROLIUK 
et al. (1988) and GALAKTIONOVA et al. (1998), 
respectively. All methods used are described in detail 
in our previously published study (AKRAMAS et 
al., 2015). 
Histology. The samples from the injected paws 
and liver were fixed in 10% neutral formalin solution. 
After decalcification and paraffin embedding, 
sections of 5 micrometer thickness were stained 
with hematoxylin-eosin, picrofuchsin and toluidine 
blue for histopathological examination under a light 
microscope. Double blind histological assessment 
of changes in the tissues was performed using a 
4-point score (0-3), where 0 indicated the absence 
of changes, 1 - minimal changes, 2 - moderate 
changes, 3 - severe changes.
Level of IL-17 and IL-1β in blood serum. 
The level of IL-17 was measured by enzyme-
linked immunosorbent assay (ELISA), using a kit 
specific for rats (ab119536-IL-17 Rat ELISA Kit) 
according to the procedure recommended by the 
manufacturer’s instructions (ELISA Abcam®, UK). 
IL-1β levels in the blood serum were measured 
using a Thermo Scientific Rat IL-1β ELISA Kit. 
Each sample was assayed in duplicate.
Statistics. Statistical analysis was done by one-
way analysis of variance ANOVA using PRISM 
Software (GraphPad Software, San Diego, CA, 
USA) followed by the Student’s t test. The non-
parametric Mann-Whitney U test was used to 
evaluate histological changes. All data were 
expressed as the mean ± SEM, and considered to be 
statistically significant at P<0.05. The results of the 
tested groups were compared with the results of the 
control AA group.
Results
Clinical and hematological data. No 
macroscopic changes in the internal organs were 
found at the end of the experiment. The weight of 
the kidney and spleen was significantly lower by 
12.4% (P<0.05) and 23.7% (P<0.01) respectively 
in the group of animals treated with CurQfen, 
indicating the positive effect of this extract (Table 
1). Treatment with Standard turmeric extract only 
markedly decreased the spleen weight by 18.4% 
(P<0.01).
Both turmeric extracts significantly reduced joint 
swelling (Fig. 1), but CurQfen was more effective. 
At the end of the experiment, joint swelling was 
reduced by 53.6% (P<0.0001) in the CurQfen 
group, and by 41.3% (P<0.001) in the Standard 
extract group, so the CurQfen was more effective 
by 12.3%. 
The analysis of blood parameters at the end 
of the experiment (Fig. 2) showed a statistically 
significant decrease in ESR in both treated groups 
(P<0.0001). 
Leukocytosis was significantly reduced: the 
Standard extract decreased the leukocyte count 
by 42.1% (P<0.001) and CurQfen - by 48.6% 
(P<0.001).
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Table 1. Body and organ weight in rats with AA, treated with turmeric extracts
Groups Body weight (g)
Relative weight of organs (g/kg-1)
Liver Kidneys Spleen Thymus
I AA + C. longa 233.28 ± 10.65 3.27 ± 0.09 0.80 ± 0.02 0.31 ± 0.01* 0.22 ± 0.02
II AA + CurQfen 238.71 ± 14.11 3.16 ± 0.09 0.78 ± 0.02* 0.29 ± 0.02* 0.27 ± 0.01
III AA control 223.12 ± 11.71 3.42 ± 0.15 0.89 ± 0.04 0.38 ± 0.02 0.24 ± 0.02
Adjuvant arthritis (AA) was induced by injection 0.1 mL of Freund’s complete adjuvant (FCA) into the left hind paw. The test 
groups with AA were treated from the day AA was induced: Group I - Standard turmeric extract (Curcuma longa; 30 mg/kg), 
Group II - dry CurQfen (30 mg/kg), Group III - AA control without treatment. The preparations were suspended in 1% starch gel 
and injected through the probe into the stomach in a volume of 1 mL, five times a week. The control AA group received the same 
volume of starch gel. * The differences are significant in comparison with the control AA group. 









Alteration of parenchyma 0.57 ± 0.07 0.57 ± 0.07 0.64 ± 0.09




Lymphocytes 0.57 ± 0.07 0.21 ± 0.10* 0.71 ± 0.10
Macrophages 0 0 0.07 ± 0.07
General 0.57 ± 0.07 0.21 ± 0.10* 0.71 ± 0.10
Penetration into the lobule 0.28 ± 0.15 0* 0.43 ± 0.17
Fibrosis 0.21 ± 0.10* 0.21 ± 0.15* 0.71 ± 0.10
C. longa (a standard turmeric extract - 95% of curcuminoids) - 30 mg/kg; dry CurQfen - 30 mg/kg. * The differences are 
significant in comparison with the control AA group. 











Leukocytes 0.83 ± 0.36 0.70 ± 0.12* 1.71 ± 0.39
Edema 0.83 ± 0.10* 1.20 ± 0.25* 2.29 ± 0.10
Angiomatosis 0.92 ± 0.15* 1.60 ± 0.19 2.00 ± 0.15
Fibrosis 1.25 ± 0.21* 1.00 ± 0.22* 0
γ-metachromasia 0.58 ± 0.20* 0.20 ± 0.12* 1.36 ± 0.18
Synovium
Proliferation 1.67 ± 0.17* 1.20 ± 0.12* 2.21 ± 0.15
Edema 0.67 ± 0.10* 0.70 ± 0.12* 1.29 ± 0.18
Inflammatory
infiltration
Lymphocytes 1.33 ± 0.17 0.60 ± 0.29* 1.79 ± 0.15
Leukocytes 0.50 ± 0.22* 0.10 ± 0.10* 1.43 ± 0.33
General 1.50 ± 0.13* 0.60 ± 0.24* 2.00 ± 0.15
Fibrosis 0.75 ± 0.21* 0.60 ± 0.37 0
Cartilage
Erosion 0.33 ± 0.17* 0.10 ± 0.10* 1.36 ± 0.28
Pannus 0.50 ± 0.22* 0.20 ± 0.20* 1.43 ± 0.27
Thinning of cartilage 0.17 ± 0.17* 0* 0.71 ± 0.18
Each parameter was scored on a 0 to 3 point scale, where 0 means the absence of changes, 1 - minimal changes, 2 - moderate 
changes, 3 - severe changes. * The differences are significant in comparison with the control AA group. 
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Fig. 1. Swelling of joints in rats with adjuvant arthritis 
(AA) treated with turmeric extracts. Standard turmeric 
extract from Curcuma longa (95% of curcuminoids; 30 
mg/kg), and dry CurQfen extract (30 mg/kg).   
* The differences are significant in comparison with the 
control AA group.
Fig. 2. Blood indices (leukocyte count and erythrocyte 
sedimentation rate) in rats with adjuvant arthritis (AA) 
treated with turmeric extracts. Standard turmeric extract 
from Curcuma longa (95% of curcuminoids; 30 mg/kg), 
and dry CurQfen extract (30 mg/kg). * The differences 
are significant in comparison with the control AA 
group.
Fig. 3. Pro-/antioxidant activity (catalase, antioxidant activity - AOA, malondyaldehyde - MDA) in rats with 
adjuvant arthritis (AA) treated with turmeric extracts. Standard turmeric extract from Curcuma longa (95% of 
curcuminoids; 30 mg/kg), and dry CurQfen extract (30 mg/kg). * The differences are significant in comparison with 
the control AA group.
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Fig. 4. Interleukin (IL-17 and IL-1β) levels in rats 
with adjuvant arthritis treated with turmeric extracts. 
Standard turmeric extract from Curcuma longa (95% of 
curcuminoids; 30 mg/kg), and dry CurQfen extract (30 
mg/kg). * The differences are significant in comparison 
with the control AA group.
The effect of turmeric extracts on lipid 
peroxidation and antioxidant activity. The AA-
induced serum lipid peroxidation defined by 
MDA (Fig. 3), decreased significantly by 32.9% 
(P<0.001) after treatment with the Standard extract, 
while the use of CurQfen lowered the MDA level 
by 17.2% (P<0.02). CAT activity in Group I and 
Group II increased by 12.6% and 34.5% (P<0.01), 
and the total antioxidant activity (AOA) - by 56.7% 
(P<0.001) and 60.4% (P<0.001) respectively, 
compared to the control AA group. 
The effect of turmeric extracts on serum IL-17 
and IL-1β levels. Changes in cytokine IL-17 and 
IL-1β levels in blood serum after treatment with the 
two turmeric extracts are shown in Fig. 4. Turmeric 
extracts diminished serum levels of IL-17 by 38.1% 
(Standard, P>0.05) and 72.9% (CurQfen, P<0.01). 
Only CurQfen had a significant impact compared to 
the control AA group.
Although serum levels of IL-1β in Groups I and II 
were lower than in the control AA group, a significant 
reduction in this cytokine was only detected in the 
group treated with CurQfen (42.8%, P<0.05). The 
treatment with Standard extract reduced the amount 
of IL-1β insignificantly (27.3%). 
Histological changes in the liver. Changes 
in the liver after treatment of AA with the two 
turmeric extracts are presented in Table 2. Both 
extracts significantly reduced lobular vena centralis 
hypervolemia compared to the control AA group 
(Standard, P<0.05; CurQfen, P<0.01).
The lymphocytic infiltration of the hepatic 
stroma (P<0.01) and the general inflammatory 
response (P<0.01) were significantly lower after 
the treatment with CurQfen. No penetration of 
inflammatory cells into the hepatic stroma (P<0.05) 
was observed after the treatment. Both turmeric 
extracts (Standard - P<0.01; CurQfen - P<0.02) 
strongly inhibited fibrotic processes in the liver 
compared to the control AA group.
Histological findings in the joints. Histological 
changes in the joint tissues are presented in Table 
3 and Fig. 5. CurQfen extract significantly reduced 
inflammatory infiltration with leukocytes in the soft 
periarticular tissues by 59% (P<0.01), as compared 
to the control AA group. This effect was not detected 
when using the Standard turmeric extract. 
Both tested extracts significantly suppressed 
soft tissue edema: the Standard extract diminished 
it by 63.8% (P<0.0001) and the CurQfen extract 
- by 47.6% (P<0.002). A significant reduction in 
blood vessel proliferation was observed after using 
Standard turmeric extract (P<0.001). Meanwhile, 
fibrosis was stimulated after treatment with both 
extracts (P<0.001) compared with the control AA 
group, in which no signs of fibrosis were detected. 
Although both extracts inhibited γ-metachromasia, 
CurQfen showed a more pronounced effect (85.3% 
decrease compared to the controls, P<0.001) while 
Standard extract showed a smaller decrease (57.4%, 
P<0.001). Synovial proliferation was significantly 
inhibited by both extracts (Standard - 24.4%, 
P<0.05; CurQfen - 45.7%, P<0.001).
Statistically significant differences between 
the treated and the control AA groups were found 
in assessing synovial edema, with similar levels 
of inhibition (by 48% in Group I, P<0.02 and 
by 45.7% in Group II, P<0.02). Both extracts 
significantly reduced synovial inflammatory 
leukocytic infiltration (Standard extract - by 65%, 
P<0.05; CurQfen - by 93%, P<0.01). CurQfen also 
significantly decreased lymphocytic infiltration of 
the synovial membrane by 66% (P<0.01), while 
R. Bradūnaitė et al.: Anti-arthritic activity of turmeric extracts 
Vet. arhiv 90 (4), 393-402, 2020 399
the Standard extract induced only a 25.7% lower 
infiltration (changes were near to significant; t 
= 2.03) compared with the control AA group. 
General inflammatory response was diminished by 
both extracts (Standard extract - by 25%, P<0.05; 
CurQfen - by 70%, P<0.001).
No fibrotic processes in the synovial membrane 
were observed in the control AA group, but were 
significantly enhanced after using the Standard 
turmeric extract (P<0.01), while treatment with 
CurQfen only increased fibrosis insignificantly. 
The hyaline cartilage erosions were significantly 
reduced in the Standard and CurQfen groups, by 
75.7% (P<0.02) and 92.6% (P<0.002), respectively. 
Both extracts significantly inhibited pannus 
formation (Table 3; Fig. 5), but a more pronounced 
effect was detected from using CurQfen (86% 
inhibition vs. control; P<0.01) and a smaller effect 
- with Standard extract (65%, P<0.05). Only one 
rat in Group I showed cartilage thinning, which 
significantly differed from the control AA group 
(P<0.05). No signs of cartilage thinning were 
detected in the CurQfen group (P<0.002 compared 
with the control AA group). 
Summarizing pathological changes in the joints, 
we conclude that the CurQfen extract showed a more 
positive effect on soft periarticular tissues than the 
Standard extract (inhibition of leukocyte infiltration 
and γ-metachromasia). CurQfen improved the 
structure of the synovium by diminishing synovial 
membrane proliferation, decreasing leukocyte 
infiltration, and by reducing cartilage erosions and 
pannus formation. 
Discussion 
In recent years, many researchers have 
been looking intensively for biologically active 
substances in various plants and trying to apply 
them for treatment of inflammatory processes, 
including RA (JIANG et al., 2010; GANESAN et 
al., 2016). Joint inflammation is also not rare in 
domestic animals. In veterinary practice, turmeric 
extracts are used in dogs, chickens, cows, mice, and 
calves (COMBLAIN et al., 2017; DANESHYAR 
et al., 2012; KARAMALAKOVA et al., 2019, 
WINKLER et al., 2015). In this study using rats 
with AA, we investigated the antioxidative, anti-
inflammatory and immunomodulatory effects 
of two dry turmeric extracts produced by the 
pharmaceutical company Aksada. Since in our 
previous investigations performed with herbal 
preparations their effects were compared with 
the effect of diclofenac (AKRAMAS et al., 2015; 
AKRAMAS et al., 2017), in this study we only 
included a control group. Diclofenac showed 
the same or a slightly greater positive effect than 
Fig. 5. Histological image of joint cartilage in rats with 
adjuvant arthritis after treatment with turmeric extracts. 
A - Standard turmeric extract from Curcuma longa (95% 
of curcuminoids; 30 mg/kg): prevailing smooth surface 
of hyaline cartilage, small remnants of pannus. B - dry 
CurQfen (30 mg/kg): no pannus, smooth articular surface 
without erosion, consolidation of subchondral bone. 
C - AA control without treatment: continuous pannus, 
erosion of hyaline cartilage. H&E, ×100.
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turmeric extracts. In order to decrease the number 
of animals used, the healthy control group was not 
included in this study. In our previous experiments 
we showed that all investigated indices in the 
tested groups significantly differed from the group 
of healthy rats (AKRAMAS et al., 2017). Both 
extracts were used in weight-calculated doses 
corresponding to human doses. CurQfen extract 
is better absorbed and reaches many times greater 
concentrations in plasma compared to Standard 
extract (KRISHNAKUMAR et al., 2015; KUMAR 
et al., 2016). Therefore, we believe that its effect is 
superior to the effect of Standard extract. Although 
both investigated extracts significantly reduced 
joint swelling, the CurQfen extract was 12.3% 
more effective than the Standard extract. 
It is known that pro-inflammatory cytokines, such 
as IL-1β, IL-17, TNF-α, and IL-6, play a detrimental 
role in the inflammatory processes. TNF-α and 
IL-6, mainly produced by M1 macrophages, are 
considered to be major pro-inflammatory cytokines 
in the RA, and both are responsible for joint damage 
(MATEEN et al., 2016). IL-1β plays a significant 
role in the pathogenesis of arthritis (KUNCHA et 
al., 2013; WU et al., 2018; ABOREHAB et al., 
2017). IL-17 enhances production of IL-1β, TNF-α 
and IL-6 in RA patients (SHI et al., 2015). Its 
concentration significantly increases in rats with AA, 
compared with healthy animals, as demonstrated in 
our previous study (AKRAMAS et al., 2017). In 
the present study both extracts improved the blood 
indices and reduced the amount of IL-17 and IL-1β, 
however only CurQfen significantly inhibited these 
interleukins, as compared with the control AA group. 
No adverse animal behavior or clinical signs 
were observed in the rats treated with turmeric 
extracts. Histological examination showed less 
damage in the hepatic parenchyma and stroma 
in turmeric treated AA groups than in the control 
group.
A significantly higher leukocyte count and 
ESR were found in the control rats with AA than 
in the turmeric treated groups. Turmeric extracts 
improved blood parameters, reduced the level of 
pro-inflammatory cytokines, and showed a non-
toxic effect.
Our study shows that CAT activity and AOA 
are lower in animals with AA. Reduced activity of 
antioxidant enzymes correlates with increased lipid 
peroxidation, measured by the amount of MDA. 
The MDA is a good index of lipid peroxidation 
products (HUANG et al., 2012). Our data showed 
that MDA levels were significantly lower in the 
turmeric treated groups. These results corresponded 
to other authors’ findings, which showed that 
turmeric extracts could reduce inflammation, 
enhance antioxidant activity and eliminate the direct 
damaging effect of free radicals (TATY ANNA et 
al., 2011; NONOSE et al., 2014). 
In summary, our data show that turmeric extracts 
significantly improve the clinical, biochemical, 
immunological and histological indices of the 
pathological process in rat AA. Turmeric extracts 
display anti-inflammatory effects, suppress 
oxidative stress and inhibit the pathological process 
in arthritic joints. 
We conclude that these extracts, particularly 
CurQfen, can be useful in the treatment of human 
and animal rheumatic diseases, in addition to 
traditional drug therapy. 
Since they enhance anti-inflammatory, 
antioxidative and immunosuppressive activity 
in experimental arthritis, they can serve as 
preventive or therapeutic agents for treatment of 
autoimmune diseases, whether as mono-therapy 
or in combination with other drugs, to alleviate the 
side effects of medication.
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sAžetAK
Cilj ovoga istraživanja bio je procijeniti antioksidacijske, imunomodulacijske i antiartritične učinke ekstrakta 
kurkume (standardni i CurQfen) na štakore s adjuvantnim artritisom. Istražen je utjecaj ekstrakta kurkume na 
prooksidacijski i antioksidacijski status, serumske interleukine IL-17 i IL-1β, krvne pokazatelje, otekline zglobova i 
histološke promjene u zglobovima i jetri te na tjelesnu masu. Oba su ekstrakta kurkume dovela do poboljšanja krvnih 
pokazatelja, smanjila su razine proupalnih citokina i poboljšala antioksidacijski status. Također su oba ekstrakta 
kurkume smanjila otekline i normalizirala histološku strukturu u mekim periartikularnim tkivima, sinovijskoj 
membrani i zglobnoj hrskavici. Nije zapažen negativan učinak na jetru. CurQfen je bio učinkovitiji od standardnog 
ekstrakta. Jaki antioksidacijski, protuupalni i imunomodulacijski učinci ekstrakta kurkume pokazuju da on može 
biti koristan u liječenju autoimunosnog artritisa kao monoterapija ili u kombinaciji s tradicionalnim lijekovima za 
liječenje artritisa. 
Ključne riječi: ekstrakti kurkume; antioksidacijska aktivnost; adjuvantni artritis; štakori_____________________________________________________________________________________________
